Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Levetiracetam Efficacy and Safety as First-line Treatment of Neonatal Seizures Occuring in Hypoxic-ischemic Encephalopathy Context

NCT02229123 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT02229123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02229123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Levetiracetam Efficacy and Safety as First-line Treatment of Neonatal Seizures Occuring in Hypoxic-ischemic Encephalopathy Context
Lead sponsor
University Hospital, Tours
Phase
Phase 2
Overall status
Completed
Start date
February 27, 2018
Completion date
February 23, 2022
Enrollment
18 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal seizures